Keyphrases
Azithromycin
100%
Randomized Placebo-controlled Trial
100%
Mali
100%
Mass Drug Administration
100%
Cluster Randomized Trial
100%
Clinical Trials
100%
Blood Culture
50%
Statistical Analysis Plan
50%
Sepsis Diagnosis
50%
Bacterial Sepsis
50%
Antibiotic Susceptibility Testing
50%
Benin
50%
Clinical Laboratory
20%
Testing Capacity
20%
Sepsis
20%
Antimicrobial Resistance
16%
Seasonal Malaria Chemoprevention
16%
Sub-Saharan Africa
11%
Health-promoting Lifestyle
10%
Trial Registration
10%
Administration Regimen
10%
Mortality Impact
10%
Health Impact
10%
Large-scale Assessment
10%
High Mortality
10%
Placebo-controlled
10%
Technical Skills
10%
Escherichia Coli
10%
Gram-positive
10%
Staphylococcus Aureus
10%
Pharmacy
10%
Results Communication
10%
Salmonella
10%
Pharmacist
10%
Quality Assurance
10%
Empiric Antibiotics
10%
Identication
10%
Antibiotics
10%
Antibiotic Use
10%
Most Common Cause
10%
Common Bacteria
10%
Communication Efficiency
10%
Interview-based
10%
Serovars
10%
Enterica
10%
Laboratory Staff
10%
Quality of Testing
10%
Laboratory Testing
10%
Laboratory Diagnosis
10%
Pneumonia
10%
Medicine and Dentistry
Azithromycin
100%
Placebo
100%
Drug Administration
100%
Clinical Trial
100%
Arm
100%
Clinician
50%
Sepsis
50%
Blood Culture
50%
Antibiogram
50%
Antibiotics
20%
Antibiotic Resistance
16%
Chemoprophylaxis
16%
Cluster Randomized Trial
10%
Diagnosis
10%
Laboratory Test
10%
Antibiotic Therapy
10%
Serotype
10%
Escherichia coli
10%
Staphylococcus Aureus
10%
Salmonella
10%
Adverse Outcome
5%
Nutritional Status
5%
Adverse Event
5%
Holoendemic
5%
Parasitemia
5%
Intention-to-Treat Analysis
5%
Relative Risk Reduction
5%
Nonoxinol 9
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Administration
100%
Clinical Trial
100%
Azithromycin
100%
Placebo
100%
Sepsis
50%
Antibiotics
33%
Salmonella
16%
Staphylococcus Aureus
16%
Escherichia coli
16%
Antibiotic Therapy
16%
Antimicrobial Resistance
16%
Cluster Randomized Trial
10%
Adverse Event
5%
Adverse Outcome
5%
Inflammation
5%
Parasitemia
5%
Nonoxynol-9
5%
